Metformin causes cancer cell death through downregulation of p53-dependent differentiated embryo chondrocyte 1

BACKGROUND: Metformin is the most commonly used first-line medicine for type II diabetes mellitus. Acting via AMP-activated protein kinase, it has been used for more than 60 years and has an outstanding safety record. Metformin also offers protection against cancer, but its precise mechanisms remain...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Biomed Sci
Main Authors: Hsieh Li, Shu-Man, Liu, Shu-Ting, Chang, Yung-Lung, Ho, Ching-Liang, Huang, Shih-Ming
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6238313/
https://ncbi.nlm.nih.gov/pubmed/30442142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-018-0478-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados